Outcomes of Surgery for Atrial Functional Mitral Regurgitatio

Not Applicable

Conditions: Atrial Functional Mitral Regurgitation
Cardiovascular - Other cardiovascular diseases

Registration Number: ACTRN12624000705583

Lead Sponsor: The Alfred

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: ot yet recruiting

Sex: All

Target Recruitment: 40

Inclusion Criteria

Candidates must meet all of the following criteria to be enrolled in the study.
•Is ambulatory, able and willing to comply with the study protocol and has provided written informed consent
•Has undergone mitral valve surgery between January 2014 to December 2022 for AFMR.

Exclusion Criteria

Candidates will be excluded from enrolment in the study if any of the following conditions apply.
•Patients who have already deceased (mortality will be included in the secondary outcome).

Study & Design

Study Type: Observational

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mitral valve and left ventricular function on follow up study [TTE upon recruitment. All patients are beyond 12 months post surgery.];evidence of heart failure[New York Heart Association (NYHA) classification and serum B-Type Natriuretic Peptide (BNP) upon recruitment. All patients are beyond 12 months post surgery.];Exercise tolerance [NYHA classification upon recruitment. All patients are beyond 12 months post surgery.]

Secondary Outcome Measures

Name	Time	Method
mortality<br>major adverse cardiac events (MACE)<br>reintervention rate<br>rate of readmission for heart failure [all-cause mortality, stroke, worsening heart failure, hospitalization for congestive heart failure, need for reintervention, permanent pacemaker implantation and prosthetic valve infection. The follow up timepoint will occur from date of mitral valve surgery for AFMR until when the patient is able to return to the hospital and attend the follow up, research related appointment (that is the follow-up timepoint). Upon recruitment, all postoperative events will be reviewed via the medical records. ];health status. [Kansas City Cardiomyopathy Questionnaire (KCCQ-12) upon recruitment, at the time of TTE. All patients are beyond 12 months post surgery.]